Clinical and Pathophysiological Considerations Related to the Impact of Bulevirtide, a New Entry Inhibitor, in HBV-HDV Infection.
Saved in:
| Title: | Clinical and Pathophysiological Considerations Related to the Impact of Bulevirtide, a New Entry Inhibitor, in HBV-HDV Infection. |
|---|---|
| Authors: | Barbu, Raisa Eloise1,2,3,4 (AUTHOR), Ignat, Mariana Daniela1,2,3,5 (AUTHOR), Bogdan Goroftei, Roxana Elena2,3,4,6 (AUTHOR), Baltă, Alexia Anastasia Ștefania1,2,4,7,8 (AUTHOR), Lutenco, Valerii1,2,5,7,9 (AUTHOR), Bulza, Valentin1,2,6,10 (AUTHOR), Stoian, Valerian Ionuț1,2,7,11 (AUTHOR), Cambrea, Simona Claudia8,12,13 (AUTHOR), Dumea, Elena9,12,13 (AUTHOR), Baroiu, Liliana2,3,5,10 (AUTHOR) |
| Source: | Viruses (1999-4915). Apr2026, Vol. 18 Issue 4, p477. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19994915 |
|---|---|
| DOI: | 10.3390/v18040477 |